RxDoctor Payments Data

Katrina Wright, MD

Nephrology · Merrillville, INNPI 1073501136

Payments from drug & device makers

$1,581in general payments, 2019–2025

Across 72 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$383
  • Fresenius USA Marketing, Inc.$324
  • Otsuka America Pharmaceutical, Inc.$204
  • Amgen$124
  • OPKO Pharmaceuticals, LLC$106
  • EKOS Corporation$93
  • plus $348 from 7 others

What the payments were for

  • Food & beverage$1,54598%
  • Education$372%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,581 in reported general payments places this provider in the 55th percentile of 238 nephrology providers in Indiana.

See all nephrology providers in Indiana

Medicare billing

Part B allowed, 2024
$208,294
Medicare patients
410
Services billed
1,854

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide20$67,709
FarxigaDapagliflozin Propanediol48$46,803
OzempicSemaglutide14$13,650
Sevelamer Carbonate12$1,413
Nifedipine ErNifedipine12$511
Hydralazine Hcl44$498
Amlodipine Besylate84$405
Potassium Chloride13$303
Metoprolol Tartrate23$244
Calcitriol45$196
Rosuvastatin Calcium19$183
Carvedilol20$173
Losartan Potassium16$132
Hydrochlorothiazide49$132
Allopurinol14$115

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$324$67,70920 claims
AstraZenecaFarxiga$383$46,80348 claims
Novo NordiskOzempic$89$13,65014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 238 nephrology providers in Indiana.

Other nephrology in Merrillville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →